Brain imaging for Parkinson's and related diseases
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study uses a special PET scan to look at a protein in the brain that is linked to certain movement and memory disorders. It aims to improve diagnosis of these conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old
- You must have either Parkinson's disease, multiple system atrophy, or dementia with Lewy bodies, or be a healthy volunteer
- You must be able to have a PET scan (an imaging test)
- You must not be pregnant or breastfeeding
- You must agree to use birth control during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special brain scan (PET/CT) to look at a protein called alpha-synuclein in people with Parkinson's disease. The goal is to learn more about the disease and how it affects the brain.
This trial uses a new imaging agent (like a dye) to see signs of Parkinson's disease in the brain. If you have Parkinson's or a related condition like Lewy body dementia or multiple system atrophy, this scan may help researchers better understand these illnesses.
This study uses a special PET scan to look at inflammation in the brain of people with Parkinson's disease or those at risk for it. The goal is to better understand the disease and possibly find new ways to track its progression.
This research study tests a new type of brain scan (called a PET scan) that may help detect early signs of Parkinson's disease and similar conditions. You'll receive the scan and may have a spinal tap to check for specific protein markers.
This study uses a new PET scan tracer called [11C]SY08 to take pictures of the brain in people with Parkinson's, multiple system atrophy, or dementia with Lewy bodies. It aims to see if this tracer can help better understand and tell apart these conditions.
This trial uses a special PET scan to see how a new imaging agent (called 11C-M503) travels through the body and brain. It may help researchers better understand brain conditions like Parkinson's disease.
Hear when a new Synucleinopathies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.